Angelini Ventures' CEO Paolo di Giorgio discusses investment strategy for Life Sciences and BioTech with Innflifes

In a recent interview with Simona Regina from the online magazine Innlifes, Angelini Ventures' CEO Paolo di Giorgio shared his insights into the company's investment strategy for the Life Sciences and BioTech industries. He discussed the unique challenges and opportunities in these sectors, as well as his outlook on the future of care.

Furthermore, he shares details on the first three investments that Angelini Ventures has made this year.

This article provides a valuable perspective on the current state and future direction of the Life Sciences and Biotech industries, as well as Angelini Ventures' role in supporting and driving innovation in these areas.

Don't miss the full story – click to read about the most recent investments of Angelini Ventures

Disclaimer: 🇮🇹 This content is in Italian.